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Abstract
Background: Recent work has identified that many long mRNA-like noncoding RNAs (lncRNAs) are expressed in the 
developing nervous system. Despite their abundance, the function of these ncRNAs has remained largely unexplored. 
We have investigated the highly abundant lncRNA RNCR2 in regulation of mouse retinal cell differentiation.
Results: We find that the RNCR2 is selectively expressed in a subset of both mitotic progenitors and postmitotic retinal 
precursor cells. ShRNA-mediated knockdown of RNCR2 results in an increase of both amacrine cells and Müller glia, 
indicating a role for this lncRNA in regulating retinal cell fate specification. We further report that RNCR2 RNA, which is 
normally nuclear-retained, can be exported from the nucleus when fused to an IRES-GFP sequence. Overexpression of 
RNCR2-IRES-GFP phenocopies the effects of shRNA-mediated knockdown of RNCR2, implying that forced 
mislocalization of RNCR2 induces a dominant-negative phenotype. Finally, we use the IRES-GFP fusion approach to 
identify specific domains of RNCR2 that are required for repressing both amacrine and Müller glial differentiation.
Conclusion: These data demonstrate that the lncRNA RNCR2 plays a critical role in regulating mammalian retinal cell 
fate specification. Furthermore, we present a novel approach for generating dominant-negative constructs of lncRNAs, 
which may be generally useful in the functional analysis of this class of molecules.
Background
Recent studies have demonstrated that non-protein cod-
ing RNAs (ncRNAs) comprise much of the mammalian
transcriptome [1]. Several thousand mammalian ncRNAs
have been identified that span multiple kilobases in
length [2]. Some of these ncRNAs show extensive conser-
vation at the nucleotide level, despite lacking evolution-
arily conserved open reading frames (ORFs). Many also
show characteristics reminiscent of protein-coding
mRNAs, such as splicing, transcription by RNA Poly-
merase II, polyadenylation, and 5'capping [3].
Perhaps the best characterized mRNA-like ncRNAs are
the Xist/Tsix transcripts, which mediate X-inactivation in
placental mammals [4]. Other long ncRNAs such as Air
and H19 have been implicated in genomic imprinting
[5,6]. In both of these cases, ncRNAs act locally, coating
the nearby genomic loci and inducing the formation of
heterochromatin and repression of gene expression [7].
Recent studies have identified other long ncRNAs that
regulate transcription at loci on different chromosomes
[8]. Some of these ncRNAs may function as RNA-based
transcriptional coregulators [9,10]. Other vertebrate long
ncRNAs have been implicated in the regulation of protein
translation [11] and signal transduction [12] and they are
likely to fulfill diverse cellular functions.
Previous work has shown that many long ncRNAs are
selectively expressed in the developing nervous system
[13]. No functional data on their role in neuronal devel-
opment is available for the vast majority of neuronally-
expressed lncRNAs, however. Two notable exceptions are
Evf-2, which regulates Dlx2-dependent activation of tran-
scription of Dlx6 and development of GABAergic neu-
rons [14,15], and Tug1, which regulates retinal rod
photoreceptor development and survival [16]. The devel-
oping retina, in particular, expresses a diverse assortment
of lncRNAs. Many of these are transcribed in an a diver-
gent, head-to-head fashion with over one third of reti-
nally-expressed transcription factors [17]. Other classes
of lncRNAs, which are not located near protein-coding
genes, are also strongly expressed in the retina. The most
abundant of these, which represents nearly 0.2% of all
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polyadenylated RNA in the neonatal retina was first
described as Retinal Non-coding RNA 2 (RNCR2), also
known as both Gomafu and Miat [18-20]. This 9 kb
ncRNA is expressed widely in the developing nervous
system in an uncharacterized subset of neural precursor
cells and is targeted to an as yet uncharacterized domain
of the nucleus. In this study, we perform a detailed analy-
sis of the cellular expression pattern and the function of
RNCR2 in retinal differentiation. In addition, we devised
an experimental strategy to develop dominant-negative
forms of RNCR2.
Results
Evolutionary conservation and genomic organization of 
RNCR2
To determine the extent to which RNCR2 is evolutionary
conserved and to identify functionally important
domains, we examined genomic and cDNA sequence
data from other vertebrates. RNCR2, which does not lie
within 20 kb of any known protein coding gene, showed
extensive sequence conservation and little diversity of
splicing among mammals (Figure 1). Though conven-
tional sequence alignment searches did not identify any
nonmammalian orthologues of RNCR2 [19], a synteny-
based search identified putative RNCR2 orthologues
from chick and Xenopus tropicalis. Multiple clustered
sequence repeats of the sequence ACUAACC were found
in the largest exon of each orthologue, with anywhere
from five to eight such repeats found within each tran-
script. A genome-wide search of human and mouse
cDNA sequences did not identify any other transcripts
with more than one evolutionarily conserved ACUAACC
repeat (data not shown). This repeat sequence includes
the ACUAAY consensus recognition site for the RNA
binding protein Quaking, which regulates both RNA sub-
cellular localization and stability [21,22], although the
functional significance of this is unclear.
Cellular expression pattern of RNCR2 in developing retina
We next performed fluorescent in situ hybridization
(fISH) for RNCR2. RNCR2 has a strikingly punctuate
expression pattern in the developing retina at E16.5, with
cells that strongly express RNCR2 intermingled with cells
that express it weakly or not at all (Figure 2A). RNCR2
expression declines after the first few days postnatal, and
by P8 is confined to a subset of cells in the inner nuclear
layer and ganglion cell layer of the peripheral retina (Fig-
ure 2C). RNCR2 RNA is exclusively nuclear at this stage
and excluded from DAPI-stained chromatin (Figure 2D),
as previously reported for the embryonic retina [19]. As
previously reported [18], RNCR2 is not detectably
expressed in adult retina.
To determine which cells express RNCR2 in the devel-
oping retina, we used the results of a previous genome-
scale analysis of gene expression in the developing mouse
retina [18] to perform two-color dissociated cell fISH
using multiple probes that recognized retinal cell-specific
markers at different developmental stages (Additional
File 1). At E16.5, we find that RNCR2 is expressed in a
large fraction of cells that express the progenitor-specific
markers Chx10 and Fgf15 (Figure 2E). RNCR2 is also
expressed in many cells expressing the amacrine-specific
marker Lhx9 and Isl1, which is expressed in developing
amacrine and ganglion cells. A substantial minority of
cells at this stage expressing the photoreceptor-specific
marker Crx are RNCR2-positive (Figure 2E). A much
smaller fraction of cells expressing the progenitor-spe-
cific markers FGF15 and Chx10 expressed RNCR2 at P0.5
than did at E16.5, while expression in amacrine and pho-
toreceptor precursors remained prominent (Figure 2F).
Finally, at P7, RNCR2 expression was restricted to a sub-
set of amacrine cells (Figure 2G), in line with the
observed expression in the inner nuclear layer (INL) and
ganglion cell layer (GCL) (Figure 2C).
Loss of function of RNCR2 inhibits amacrine cell and Müller 
glia differentiation in postnatal retina
Given the prominent and selective expression of RNCR2
in the developing retina, we next employed in vivo elec-
troporation of P0.5 mouse retinas to determine whether
Figure 1 Genomic structure and evolutionary conservation of 
RNCR2. Schematic drawing showing the conservation and genomic 
position of RNCR2 based on the human March 2006, mouse July 2007, 
chicken May 2006 and Xenopus April 2005 assemblies of the UCSC Ge-
nome browser. Clusters of the conserved seven base repeat ACTAACC 
are shown below each RNCR2 transcript, with the sequence of one re-
peat cluster for each species is shown.Rapicavoli et al. BMC Developmental Biology 2010, 10:49
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RNCR2 regulates retinal cell differentiation. To visualize
electroporated cells, all constructs were coelectroporated
with plasmids that express GFP from the same CAG pro-
moter. For RNCR2, we assembled a 9 kb cDNA corre-
sponding to the previously reported full-length mouse
sequence [19] (Additional File 2). Overexpression of
RNCR2 did not give any detectable phenotype in either
section or dissociated cell immunohistochemistry (Figure
3A), and no changes in morphology or position of elec-
troporated cells were observed at P21 (Figure 3B, C).
For knockdown analysis, we tested shRNAs for their
ability to reduce expression of endogenous RNCR2
expression by in vivo electroporation of P0.5 retina.
Reduction in RNA expression was determined by fISH
analysis of P4.5 dissociated cells in conjunction with anti-
GFP immunocytochemistry to identify electroporated
cells (Additional File 3). A shRNA construct was identi-
fied that resulted in a >75% reduction in the number of
double-labeled electroporated cells at P4.5 compared to
cells electroporated with control shRNA. The shRNA-
mediated knockdown of RNCR2 led to a decrease in the
fraction of cells expressing the Müller glia marker glu-
tamine synthase (GS) at P7 (p < 0.005, Figure 4A). Two
weeks later at P21, however, a significant increase in the
f r a c t i o n  o f  bo t h  G S-po s i t i v e  M ü l l e r  g l i a  ( w h i t e  a r r o w -
heads) and syntaxin-positive amacrine cells (yellow
arrowheads, p < 0.05) was observed at P21 (Figure 4B-D).
This finding was confirmed by analysis of immunos-
tained sections of electroporated retina (Figure 4C, D).
A significant increase in the fraction of electroporated
cells in the inner nuclear layer (INL) (p < 0.04), together
w i t h  a  c o r r e s p o n d i n g  d e c r e a s e  i n  t h e  f r a c t i o n  o f  e l e c -
troporated cells in the photoreceptor-containing outer
nuclear layer (ONL) (Figure 4B, inset) was detected fol-
lowing RNCR2 knockdown, in line with the observed
increase in cells expressing amacrine and Müller glial
markers (Figure 4B). No change in the fraction of elec-
troporated cells expressing the rod bipolar marker PKCα
was observed following RNCR2 knockdown (Figure 4A,
B). Surprisingly, however, no statistically significant
reduction in the number of cells expressing the rod-spe-
cific marker Rho4D2 was observed (Figure 4B). Addition-
ally, no increase in apoptotic cell death, as indicated by
TUNEL staining, was observed following RNCR2 knock-
down at P4.5. One possible explanation is that a subset of
inner retinal cells may continue to express rhodopsin in
Figure 2 Expression of RNCR2 in the developing retina. Section fluorescent in situ hybridization (fISH) showing RNCR2 expression. RNCR2 is widely 
expressed in the retina at E14.5 (A), and in the INL and GCL at P8 (C). High-power magnification of E14.5 (B) and P8 (D) reveals that RNCR2 is localized 
to the nucleus but not associated with DNA. (E-G) RNCR2 expression examined by double dissociated-cell in situ hybridization at E16.5 (E), P0.5 (F), and 
P7 (G). Cellular expression pattern of each control probe is color coded by cell type. Some probes recognize more than one cell type. This is indicated 
by overlapping bars. For example Islet1 mRNA at E16.5 is present in developing amacrine and ganglion cells [34].Rapicavoli et al. BMC Developmental Biology 2010, 10:49
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addition to syntaxin and/or GS, although we have seen no
evidence to support this using section immunohis-
tochemistry (data not shown).
Fusion of RNCR2 to an IRES-GFP sequence results in nuclear 
export and a dominant-negative phenotype in vivo
Throughout this study, we explored additional
approaches to perturb the function of RNCR2 and to
investigate the specific function of different domains of
this molecule. One strategy used to generate dominant-
negative forms of nuclear proteins has been to construct
mutants that are sequestered in the cytoplasm, thus
blocking nuclear entry of any cofactors that interact with
the protein in question [23-26]. We used an analogous
approach to generate dominant-negative forms of
RNCR2. We adapted this strategy for analysis of RNCR2.
We hypothesized that lncRNAs such as RNCR2, like pro-
teins, must interact with cellular effector molecules to
carry out their physiological functions and that mislocal-
ization of long ncRNAs might then result in mislocaliza-
tion of the associated effector molecules. Since long
ncRNAs are not translated, the fusion of IRES-GFP
Figure 3 Overexpression of RNCR2 in the developing retina. CAG-GFP or CAG-RNCR2 construct was electroporated into P0.5 retina and harvested 
at P21, dissociated and stained for cell-specific markers. GFP-positive cells were counted to analyze the fraction of electroporated cells that expressed 
the markers in question. Error bars represent +/- SEM for at least three independent retinas. (A) CAG-RNCR2 overexpression has no effect on cell fate 
determination. The number of GFP-positive electroporated cells in ONL and INL were counted and compared (inset), with no difference was noted. 
(B-C) Section immunohistochemistry of retinas electroporated with either CAG-GFP or CAG-RNCR2 and harvested at P21 confirm no differences in cell 
fate or morphology of CAG-RNCR2 electroporated cells. Cell type specific markers used: rhodopsin (Rho4D2), rod photoreceptors, glutamine syn-
thetase (GS), Müller glia; protein kinase C alpha (PKCα), rod bipolar cells; syntaxin (Syn), amacrine cells.
Figure 4 ShRNA-mediated knockdown of RNCR2 in the developing retina. Control shRNA or RNCR2-targeted shRNA construct was electropo-
rated into P0.5 retina and harvested at P7 or P21, dissociated and stained for cell-specific markers. (A) RNCR2 knockdown led to a decrease in Müller 
glia at P7 and (B) an increase in Müller glia and amacrine cells at P21, *p < 0.05. A significant increase in GFP-positive electroporated cells in the INL 
was noted (B, inset). (C-D) Section immunohistochemistry of retinas electroporated with either control shRNA or RNCR2-targeted shRNA confirm an 
increase in Müller glia (white arrowheads) and amacrine cells (yellow arrowheads).Rapicavoli et al. BMC Developmental Biology 2010, 10:49
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sequences to ncRNAs would mislocalize these molecules
to cytoplasmic ribosomes, and away from their normal
cellular sites of action in the nucleus, titrating down the
endogenous biochemical effectors of RNCR2 action and
effectively resulting in a dominant-negative phenotype.
Figures 5A and 5B illustrate this concept schematically.
We first tested whether fusion of RNCR2 to IRES-GFP
would mislocalize the RNA to the cytoplasm. Using fISH
in conjunction with immunostaining for the ribosomal
protein S6, we observed that full-length RNCR2-IRES-
GFP constructs are mislocalized from the nucleus to the
cytoplasm when expressed in HeLa cells (Figure 5C).
Cells transfected with RNCR2-IRES-GFP showed GFP
fluorescence, indicating that these IRES-fusion con-
structs are indeed targeted to the ribosome and undergo
translation (data not shown).
We next tested whether electroporation of IRES-GFP
fusion constructs into P0.5 retina produced phenotypes
like those seen following shRNA-mediated knockdown of
RNCR2. Expression of RNCR2-IRES-GFP resulted in a
significant increase in the fraction of syntaxin-positive
cells at P7 and P21 (p < 0.05 and p < 0.001, Figure 6A,B),
as was observed with shRNA-mediated knockdown of
RNCR2 at P21 (Figure 3E), and a significant increase in
the fraction of cells in the INL and decrease in cells in the
ONL (p < .003) (Figure 6B, inset). An increase in ama-
crine cells was confirmed by section immunohistochem-
istry of electroporated retina (yellow arrowheads, 6C-D).
Furthermore, expression of RNCR2-IRES-GFP results in
a substantial increase in the fraction of cells that do not
express any of the four markers examined (Figure 6A,B).
Section immunohistochemistry indicates a roughly
two-fold increase in the fraction of electroporated cells in
the inner nuclear layer, comparable to that observed fol-
lowing shRNA-mediated knockdown of RNCR2 (Figure
4B), and overexpression of RNCR2-IRES-GFP further
resulted in a nearly two-fold decrease in the fraction of
rhodopsin-positive cells at both P7 and P21 (Figure 6A-
B). Since the decrease in the fraction of rhodopsin-
expressing cells was substantially greater than the
observed increase in the fraction of cells in the INL, this
data implies that overexpression of RNCR2-IRES-GFP
induces both a shift in electroporated retinal precursors
away from a rod photoreceptor fate and a reduction in
rhodopsin expression levels, as implied by the dramatic
increase in the fraction cells of electroporated with the
RNCR2-IRES-GFP construct that are not labeled by any
of the four markers tested. No increase in apoptotic cell
death, as indicated by TUNEL staining, was observed fol-
lowing electroporation of RNCR2-IRES-GFP at P4.5 nor
was any increase in staining for the cone-specific marker
Gtγ2 observed at P21 (data not shown) eliminating the
possibility these changes in rhodopsin expression levels
are a result of apoptosis or a change in cell fate from rod
photoreceptors to cone photoreceptors.
To further explore the phenotypes seen following
RNCR2-IRES-GFP expression, we generated domain-
specific IRES-GFP fusions corresponding to non-overlap-
Figure 5 IRES-GFP fusion constructs mislocalize RNCR2 to the cy-
toplasm. (A, B) Model for a mechanism by which overexpression of 
IRES-GFP fusion-constructs can result in dominant-negative pheno-
types in transfected cells. Fusion to the IRES-GFP sequence mislocalizes 
lncRNAs and associated effector proteins to the ribosome, and mislo-
calizes proteins that bind RNCR2 and mediate the biochemical effec-
tors of lncRNA function away from endogenous nuclear-retained 
lncRNAs, effectively inhibiting their function. (C) RNCR2-IRES-GFP RNA 
is mislocalized from the nucleus to the cytoplasm. HeLa cells were 
transfected with RNCR2 or RNCR2-IRES-GFP fusion constructs and RNA 
location analyzed by fISH followed by immunohistochemistry against 
the cytoplasmic S6 ribosomal protein. White arrows indicate regions of 
prominent RNCR2 localization. The cell nucleus, defined by the region 
encompassed by DAPI-stained chromatin, is delineated by the white 
dashed line. The relative fraction of nuclear RNCR2 signal found within 
in cells transfected with CAG-RNCR2 and CAG-RNCR2-IRES-GFP is 
shown in the bar graph. *p < 1.5-07.Rapicavoli et al. BMC Developmental Biology 2010, 10:49
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ping 2-4 kb domains of the 5', middle and 3' regions of the
9 kb RNCR2 RNA (Additional File 2), and overexpressed
these in P0.5 retina using in vivo electroporation. Section
immunohistochemistry revealed that the expression of
IRES-GFP fusion constructs of the 5' domain of RNCR2
(RNCR2 5'-IRES-GFP) led to an increase in the fraction
of amacrine cells, as was observed following overexpres-
sion of the full-length RNCR2-IRES-GFP construct (yel-
low arrowheads, Figure 7A-B). However, IRES-GFP
fusion constructs of the middle 3.8 kb of RNCR2
(RNCR2m-IRES-GFP) led to an increase in both Müller
glia (white arrowheads) and amacrine cells (yellow arrow-
heads, Figure 7C-D), while a construct including the 3'
region of RNCR2 (RNCR2 3'-IRES-GFP) led to an
increase in Müller glia only (white arrowheads, Figure
7E). The increase in Müller glia that is seen following
overexpression of the middle and 3' IRES-GFP fusion
domains mirrors that observed following shRNA-medi-
ated knockdown of RNCR2 expression (Figure 4B).
Finally, all three domain-specific IRES fusion constructs
resulted in an increase in the total fraction of GFP-posi-
tive cells in the inner nuclear layer (p < 0.003, Figure 7F),
reflecting the increase in amacrine cells and Müller glia
like that observed following shRNA-mediated knock-
down of RNCR2. We interpret these results to show that
IRES-GFP fusion constructs representing distinct
domains of RNCR2 possess different functions in control
of retinal differentiation. Since RNCR2 shRNA results in
Figure 6 Overexpression of RNCR2-IRES-GFP has dominant-negative effects in vivo. CAG-driven constructs encoding IRES-GFP or RNCR2-IRES-
GFP were electroporated into P0 retina and harvested at either P7 or P21 and analyzed. (A-B) RNCR2-IRES-GFP expression results in a decrease in rho-
dopsin expression and an increase in the fraction of amacrine cells at P7 and P21, and an increase in the fraction of GFP-positive cells not stained by 
any marker tested at P21. *p < 0.02. (C-D) Analysis of electroporated retinas at P21 confirms the increase in amacrine cells (yellow arrowheads). RNCR2-
IRES-GFP led to an increase in INL cells compared to IRES-GFP (B, inset).
Figure 7 Domain-specific RNCR2-IRES-GFP fusion constructs selectively inhibit either amacrine or Müller glia differentiation. Dominant-
negative RNCR2 constructs were electroporated in vivo at P0.5 and analyzed at P21. (A-B) Section immunohistochemistry reveals that RNCR2-5'-IRES-
GFP overexpression led to an increase in amacrine cells (yellow arrowheads), (C-E) RNCR2-middle-IRES-GFP overexpression led to an increase in Müller 
glia (white arrowheads) and amacrine cells and RNCR2-3'-IRES-GFP overexpression led to an increase in Müller glia. (F) Each of the RNCR2-IRES-GFP 
domain-specific constructs showed an increase in INL cells compared to control **p < 0.003.Rapicavoli et al. BMC Developmental Biology 2010, 10:49
http://www.biomedcentral.com/1471-213X/10/49
Page 7 of 10
an increase in the fraction of Muller glia but the full-
length RNCR2-IRES-GFP construct does not (Figure
4B,D; 6B), these findings suggest that domain-specific
IRES-GFP fusion constructs of RNCR2 may be more
effective at inhibiting differentiation of certain cell types
than the full-length construct. When taken together,
these results closely phenocopy the changes in cell fates
observed following shRNA-mediated knockdown of this
RNA.
Discussion
RNCR2 negatively regulates development of multiple 
retinal cell types
Our findings demonstrate that the overexpression and
knockdown of RNCR2 in the developing retina regulates
the process of cell fate specification. In keeping with
RNCR2's prominent and selective expression in mitotic
progenitors and postmitotic retinal precursor cells, we
observe that RNCR2 acts to negatively regulate the differ-
entiation of multiple and partially overlapping cell types
(Figure 5). This is in contrast to the role of Tug1, the only
long ncRNA previously investigated in the context of reti-
nal development [16], which positively regulates photore-
ceptor development and survival. It has recently become
clear that negative regulatory interactions play a promi-
nent and crucial role in retinal cell fate specification [27-
29]. RNCR2 represents the first long ncRNA reported to
perform this function.
These findings demonstrate that RNCR2 negatively
regulates amacrine differentiation, as both RNCR2
knockdown and RNCR2-IRES-GFP expression result in
an increase in GFP-positive cells with amacrine-like mor-
phology, as well as in syntaxin immunoreactivity. How-
ever, it seems at first glance difficult to reconcile this
finding with the fact that RNCR2 is also selectively
expressed in immature amacrine cells. Several examples
of a similar correlation of phenotype and gene expression
have been previously reported in developing retina. One
example is Pax6, which is prominently expressed in both
retinal progenitors and developing amacrine cells. When
Pax6 is selectively inactivated in retinal progenitors, a
massive overproduction of GABAergic amacrine cells is
seen [30]. It is thought that Pax6 may act in retinal pro-
genitors to inhibit premature amacrine differentiation,
but have different functions in cells already committed to
the amacrine lineage. RNCR2 may play a similar role in
retinal progenitor and precursor cells.
In addition to inhibiting the development of amacrine
interneurons, RNCR2 also inhibits the development of
Müller glia but does not affect the development of other
neuronal subtypes such as bipolar interneurons. Interest-
ingly, however, we observe that shRNA-mediated knock-
down of RNCR2 results in a reduction of cells expressing
the Muller marker GS at P7, in contrast to the significant
increase in GS-positive cells that is observed at P21. It is
possible that RNCR2 knockdown induces a delay in the
differentiation of Muller glia, which initiate expression of
GS shortly prior to P7. By P21, however, gliogenesis is
complete and all differentiated Muller glia should be
expressing detectable levels of GS. Thus, we hypothesize
that these data may result from RNCR2 knockdown
inducing a delay in Muller glia differentiation while none-
theless also inducing a shift in retinal progenitor cells
towards a glial fate. Taken together, our findings suggest
that the effects of RNCR2 loss of function on retinal cell
differentiation seen in these studies are specific and do
not represent a general developmental delay or inhibition
of neurogenesis.
Although these findings demonstrate the functional
importance of RNCR2 in retinal cell differentiation, its
molecular mechanism of action still remains unclear.
Unlike other nuclear-retained long ncRNAs such as Xist
and Air, it shows no association with chromatin and is
tightly associated with nuclear matrix [19]. It shows no
obvious structural motifs, but is conserved from amphib-
ians to mammals (Figure 1) and contains multiple puta-
tive Quaking binding sites. The biochemical mechanism
of action by which RNCR2 controls retinal cell fate speci-
fication awaits further characterization.
Mislocalization of nuclear-retained lncRNAs to the 
cytoplasm results in a dominant-negative phenotype in 
vivo
There have been no general strategies yet proposed for
the generation of dominant-negative constructs for long
ncRNAs. In this study, we demonstrate that fusion of a
nuclear-retained lncRNAs to an IRES-GFP sequence can
mislocalize exogenous ncRNAs to the ribosome, and pro-
duces phenotypes that largely overlap with those seen
with shRNA-mediated knockdown. Indeed, the overex-
pression of IRES-GFP fusion constructs encoding differ-
ent domains of RNCR2 variously increases the number of
amacrine cells, Müller glia, or both cell types like what is
seen in the RNCR2 shRNA-mediated knockdown,
depending on the domain of RNCR2 that is tested. Cer-
tain novel phenotypes are observed following overexpres-
sion of RNCR2-IRES-GFP fusions that are not seen
following RNCR2 knockdown, most notably a substantial
reduction in the fraction of rhodopsin-expressing cells. It
is possible that RNCR2 has a role in regulating expression
of rhodopsin, and that this function might be inhibited
more effectively by overexpression of the IRES-GFP
fusion than by the RNCR2 shRNA construct. However, it
is also possible that overexpression of the RNCR2-IRES-
GFP fusion construct may introduce a neomorphic phe-
notype in developing photoreceptors that is not apparent
following overexpression of RNCR2 alone (Figure 3A).
Further studies will be required to resolve this question.Rapicavoli et al. BMC Developmental Biology 2010, 10:49
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Many of the thousands of mammalian lncRNAs are
nuclear-retained [31]. Although other nuclear-retained
lncRNAs in addition to RNCR2 have been shown to be
susceptible to shRNA-mediated degradation [32], con-
ventional RNA interference approaches are in general far
less successful at reducing expression of these molecules
than cytoplasmic transcripts [33]. The fact that the IRES-
GFP sequence mislocalizes untranslated lncRNAs from
the nucleus to the ribosome may serve as a general tool
for functional analysis of these molecules.
Conclusion
We show that the long noncoding nuclear-localized RNA
RNCR2 regulates retinal cell fate specification. We find
that shRNA-mediated loss of function of RNCR2
increases the fraction of amacrine interneurons and
Müller glia at the expense of photoreceptor cells. We fur-
ther show that fusion of RNCR2 to an IRES-GFP
sequence results in mislocalization of this nuclear RNA
to the cytoplasm. This largely phenocopies the effects of
knockdown of RNCR2, and we further use this approach
to define domains of RNCR2 that inhibit amacrine and
Müller glial differentiation, respectively. This IRES-GFP
fusion technique provides a rapid, general method for
functionally analyzing nuclear-localized noncoding
RNAs in vivo, and can potentially allow one to readily




Pregnant CD1 mice were purchased from Charles River
Breeding Laboratories. Animal experiments were
approved by the Johns Hopkins University Institutional
Animal Care and Use Committee.
DNA Constructs
To make pCAGIG-RNCR2, the last 6535 BP of RNCR2
were amplified off BAC clone RP24-308B24 by PCR, cut
with EaglI and ligated into pCAGIG RNCR2 5' digested
with NotI. To make pCAG-RNCR2, RNCR2 was ampli-
fied off pCAGIG RNCR2 by PCR and cloned into pCR4
BLUNT-TOPO ((Invitrogen) per manufacture's instruc-
tions and RNCR2 was excised with NotI from pCR4
BLUNTTOPO and ligated into pCAG digested with
NotI. To make pCAG-RNCR2 5'-IRES-GFP (1-2165),
RNCR2 5'was excised from CF182323 with HincII and
NotI and ligated into pCAG and pCAGIG digested with
EcoRV and NotI. To make pCAGIG pCAG-RNCR2m-
IRES-GFP (1985-5718), RNCR2 middle was amplified off
RP24-308B24 by PCR and cloned into pCAG and pCA-
G I G  d i g e s t e d  w i t h  E c o R I .  T o  m a k e  p C A G - R N C R 2  3 ' -
IRES-GFP' (5654-8709), RNCR2 3' was excised from
BU515659 with EcoRV and NotI and ligated into pCAG
and pCAGIG digested with EcoRV and NotI. ShRNA
against RNCR2 was targeted against chr5:112,657,653-
112,657,673 (mm9 assembly, UCSC genome browser), a
site selected using Ambion's Target Finder software http:/
/www.ambion.com/techlib/misc/siRNA_finder.html. Oli-
gonucleotides were annealed and ligated into pSilencer
2.1-U6 hygro (Ambion). Control shRNAs cloned into pSi-
lencer 2.1 were previously described [36].
In Vivo Electroporation
In vivo electroporation of mouse retina was performed as
described [37]. All retinas were electroporated at P0.5.
Control and experimental constructs were co-electropo-
rated with two hundred nanograms of pCAG-GFP to
readily visualize electroporated cells [37]. For overexpres-
sion experiments either two micrograms of pCAG-GFP
or two micrograms of pCAG-RNCR2 was injected. For
shRNA mediated knockdown, two micrograms of U6-
control or two micrograms of U6-RNCR2 was injected.
For analysis of dominant-negative constructs, two micro-
grams of either pCAG-GFP or two micrograms of pCAG-
RNCR2-IRES-GFP were injected.
Cell Culture
HeLa cells were grown in DMEM supplemented with
10% FCS. Cells were transfected with Fugene6 (Roche)
according to the manufacturer's instructions, and were
harvested two days post-transfection.
Immunohistochemistry
For cryosections, electroporated eyes were harvested 21
days after electroporation, fixed for 1 hour in 4% para-
formaldehyde in PBS at 4°C and cryoprotected overnight
in 30% sucrose in PBS at 4°C before being embedded in
OCT compound (Sakura, Torrance, CA) on dry ice. 20
μm cryosections were cut on a cryostat. Retinal cryosec-
tions were immunostained as described except that sec-
tions were post fixed in 4% paraformaldehyde for 5
minutes prior to blocking [16]. Samples were photo-
graphed on a Zeiss Meta 510 confocal microscope. Elec-
troporated cells were counted in the inner nuclear layer
versus outer nuclear layer and compared for different
constructs. Cell dissociation and immunostaining of elec-
troporated retinas were preformed as described [16],
except that retinas were harvested at postnatal days 7 and
21. Samples were visualized and quantified on a Zeiss
Axioskop2 microscope. Nuclear DNA was visualized
with DAPI counterstaining. A two-tailed Student's t-test
analysis was used for statistical analysis of all cell counts
in the study. At least three retinas were counted for each
construct examined using either section immunohis-
tochemistry or dissociated immunocytochemistry, with
100-300 GFP-positive cells counted for each marker
tested.Rapicavoli et al. BMC Developmental Biology 2010, 10:49
http://www.biomedcentral.com/1471-213X/10/49
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Antibodies and antibody concentrations used for sec-
tion immunohistochemistry are as follows: anti-glu-
tamine synthetase (1:200, BD transduction laboratories
610518), anti-CHX10 (1:200, Abcam ab16142), anti-
HPC1 (1:200, Sigma S0664), and anti-green fluorescent
protein (1:1000 Invitrogen A6455). Alexa568 goat anti-
mouse IgG secondary antibody (1:500 Invitrogen
A11008) and Alexa488 goat anti-rabbit IgG (1:500, Invit-
rogen A11004).
For dissociated retinal cell immunocytochemistry the
following antibodies and concentrations were used: anti-
rhodopsin (Rho4D2, 1:2000, obtained from R. Molday,
University of British Columbia), anti-glutamine syn-
thetase (1:2000, BD transduction laboratories 610518),
anti-protein kinase Cα (1:5000 Millipore 05-154), anti-
HPC1 (1:2000, Sigma S0664), anti-green fluorescent pro-
tein (1:1000 Invitrogen A6455). Alexa568 goat anti-
mouse IgG (1:1000 Invitrogen A11008), Alexa568 goat
anti-guinea pig IgG (1:1000 Invitrogen A11075), Alexa
594 donkey anti-sheep IgG (1:1000 Invitrogen A11016)
and Alexa488 goat anti-rabbit IgG (1:1000, Invitrogen
A11004).
In Situ Hybridization
For cryosections, untimed E16.5 embryos were dissected
and fixed overnight in 4% paraformaldehyde in PBS at
4°C and cryoprotected overnight in 30% sucrose in PBS at
4°C before being embedded in OCT compound (Sakura,
Torrance, CA) on dry ice. 20 μm cryosections were cut on
a cryostat. All probe sequences used and section ISH
methodology was as previously described [18] except that
a Tyramide Signal Amplification system (TSA Plus, Per-
kin Elmer, NEL 744) combined with an antidigoxigenin-
HRP antibody (1:1000, Roche) was used according to the
manufacturer's directions. Sections were counterstained
with DAPI.
Dissociated cell fISH was preformed as described [18]
except that retinas were dissected from E16.5, P0.5, and
P7 mice and the TSA Plus Cyanine3/Fluorescein kit
(1:125, Perkin Elmer, NEL 753) was used for two color
fISH. Samples were visualized and quantified on a Zeiss
Axionskop2 microscope. Nuclear DNA was visualized
with DAPI counterstaining. Cell counts were analyzed
using the two-tailed Student's t-test. Dissociated cells
from two to three different retinas were examined for
each probe tested, and 100-300 RNCR2-positive cells
were examined for colocalization with each indicated
marker.
To quantify shRNA-mediated knockdown of RNCR2,
retinas were dissected at P4.5 and fISH was preformed as
described above using TSA Plus Cyanine3 kit (1:125, Per-
kin Elmer, NEL 744) followed by staining as described
with rabbit anti-GFP and detection with goat anti-rabbit
Alexa488. Samples were visualized on a Zeiss Axionskop2
microscope and signal intensity was quantified with
Volocity 4.0 software. HeLa cell fISH followed by immu-
nocytochemistry was performed as above except that
transfected cells were trypsin digested for 5 min at 37°C
before being plated and cytoplasmic ribosomes were
visualized with rabbit anti-S6 ribosomal protein. A mini-
mum of ten transfected HeLa cells were analyzed for each
condition tested. Samples were photographed on a Zeiss
Meta 510 confocal microscope and nuclear transcript lev-
els were quantified using Volocity 4.0 software.
Additional material
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(F), Otx2 (G) and KIAA0013 (H), respectively. At P0.5 (I-O) dissociated cells 
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Otx2 (N), and Crx (O), respectively. At P7 (P-U) cells were stained with 
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Additional file 2 RNCR2 genomic structure and constructs used. 
Genomic location of RNCR2 constructs used. Conservation is plotted in 
blue using the PhastCons program [35].
Additional file 3 Confirmation of shRNA knockdown of endogenous 
RNCR2. (A-C) A construct encoding control shRNA or shRNA targeting 
RNCR2 was electroporated into P0.5 retina in vivo and harvested at P4.5 and 
dissociated. Immunostaining for GFP (green) was then conducted in com-
bination with fISH to detect RNCR2 (red). (A) GFP positive cells were quanti-
fied to analyze the amount of RNCR2 transcript that was expressed with 
Velocity 4.0 software. At least three retinas with 100 cells per retina were 
counted for each combination. Error bars represent standard error for at 
least three independent retinas. (A) p = 0.001. (B-C) Examples of dissociated 
cells are shown.
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